Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Total Current Liabilities (2016 - 2025)

Haemonetics (HAE) has 16 years of Total Current Liabilities data on record, last reported at $539.9 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 113.19% year-over-year to $539.9 million; the TTM value through Dec 2025 reached $539.9 million, up 113.19%, while the annual FY2025 figure was $578.1 million, 92.46% up from the prior year.
  • Total Current Liabilities reached $539.9 million in Q4 2025 per HAE's latest filing, down from $548.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $578.1 million in Q1 2025 and bottomed at $180.5 million in Q3 2022.
  • Average Total Current Liabilities over 5 years is $326.9 million, with a median of $263.2 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: crashed 44.01% in 2021, then skyrocketed 113.19% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $288.5 million in 2021, then dropped by 21.35% to $226.9 million in 2022, then rose by 15.37% to $261.8 million in 2023, then decreased by 3.26% to $253.2 million in 2024, then surged by 113.19% to $539.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $539.9 million in Q4 2025, $548.3 million in Q3 2025, and $531.4 million in Q2 2025.